DAWN icon

Day One Biopharmaceuticals
DAWN

Overview Fund Activity

87 hedge funds and large institutions have $1.04B invested in Day One Biopharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 29 increasing their positions, 15 reducing their positions, and 11 closing their positions.

Holders
87
Holders Change
+21
Holders Change %
+31.82%
% of All Funds
1.47%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.07%
New
34
Increased
29
Reduced
15
Closed
11
Calls
$7.91M
Puts
$2.78M
Net Calls
+$5.13M
Net Calls Change
+$5.13M

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$122M
2
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$49.2M
3
Goldman Sachs
3
Goldman Sachs
New York
$33.9M
4
DM
4
Deerfield Management
New York
$62.9M
5
RCM
5
RA Capital Management
Massachusetts
$126M

Top Sellers

1
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$0
2
BI
2
BVF Inc
California
$0
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$47M
4
Millennium Management
4
Millennium Management
New York
$314K
5
LCM
5
Laurion Capital Management
New York
$269K
Name Market Value Shares Shares
Change 		Shares
Change %
CPX
1
Canaan Partners XI
California
$173M 9,663,645 – –
AVLSA
2
Atlas Venture Life Science Advisors
Massachusetts
$161M 8,968,305 +766,667 +9%
RCM
3
RA Capital Management
Massachusetts
$126M 7,040,622 +980,532 +16%
Fidelity Investments
4
Fidelity Investments
Massachusetts
$122M 6,826,574 +4,232,055 +163%
DM
5
Deerfield Management
New York
$62.9M 3,512,123 +1,425,674 +68%
Adage Capital Partners
6
Adage Capital Partners
Massachusetts
$49.2M 2,746,825 +2,570,976 +1,462%
Vanguard Group
7
Vanguard Group
Pennsylvania
$47M 2,626,474 -359,952 -12%
Franklin Resources
8
Franklin Resources
California
$44.1M 2,465,380 +922,521 +60%
T. Rowe Price Associates
9
T. Rowe Price Associates
Maryland
$36.5M 2,041,344 +455,603 +29%
BlackRock
10
BlackRock
New York
$35.1M 1,962,724 +799,808 +69%
Goldman Sachs
11
Goldman Sachs
New York
$33.9M 1,894,537 +1,863,325 +5,970%
Viking Global Investors
12
Viking Global Investors
Connecticut
$33.2M 1,857,424 +700,000 +60%
BC
13
Boxer Capital
California
$21.3M 1,189,943 – –
CC
14
Commodore Capital
New York
$13.2M 739,661 +739,661 New
PA
15
Perceptive Advisors
New York
$9.95M 556,047 – –
DCM
16
Driehaus Capital Management
Illinois
$8.98M 501,689 +98,231 +24%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$7.92M 442,359 +119,664 +37%
State Street
18
State Street
Massachusetts
$6.42M 358,783 +142,567 +66%
Alyeska Investment Group
19
Alyeska Investment Group
Illinois
$3.89M 217,143 +113,943 +110%
SB
20
Samsara BioCapital
California
$3.52M 196,425 -6,075 -3%
Northern Trust
21
Northern Trust
Illinois
$3.41M 190,510 +20,211 +12%
Charles Schwab
22
Charles Schwab
California
$2.74M 153,043 +49,009 +47%
WP
23
Woodline Partners
California
$2.69M 150,176 +150,176 New
Marshall Wace
24
Marshall Wace
United Kingdom
$2.61M 145,898 +128,155 +722%
D.E. Shaw & Co
25
D.E. Shaw & Co
New York
$2.48M 138,318 +138,318 New
1
2 3 4 5